EFFECT OF LISINOPRIL AND ENALAPRIL ON QUALITY OF LIFE AND BLOOD PRESSURE DAILY PROFILE IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION.

Aim. To compare effect of long-term treatment with lisinopril and enalapril on quality of life (QL) and blood pressure (BP) daily profile in patients with stable arterial hypertension (AH). Material and methods. Analysis of three studies conducted in our center during last 4 years are presented (totally 86 patients were included). Protocol of studies was unified: after wash-out period ambulatory blood pressure monitoring (ABPM) and QL were assessed. Afterwards, patients were switched to active therapy with enalapril or lisinopril. After long-term treatment with these drugs QL and ABPM and QL were assessed again. Results. Both drugs decreased in systolic and diastolic BP, time index and didn't change heart rate and night BP dipping. With lisinopril treatment, significant improvement in physical condition, efficiency at work, psychological profile and capacity for social contacts was observed, while treatment with enalapril positively influenced only on physical condition and intensity of negative psychological profile in patients with stable AH. Conclusion. In patients with stable AH lisinopril had better influence on QL than enalapril. Therapy with both drugs lead to significant decrease in systolic and diastolic BP and didn't change heart rate and night BP dipping.

1. Оганов Р.Г., Масленникова Г.Я. Смертность от сердечно-сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения России. Кардиоваскулярная терапия и профилактика 2002; 3: 4-8.

2. Collins R., MacMahon S. Blood pressure, antihyhertensive drug treatment and the risk of stroke and of coronary heart disease. Br Med Bull 1994; 50:272-298.

3. Staessen J.A., Gasowski J., Wang J.G. Risk of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000; 355:865-872.

4. Hansson L., Zanchetti A., Carruters S.G. et al. Effects of intensive blood-pressure lowering and lowe-dose aspirin in patients with hypertension: principal result of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;317:1755- 1762.

5. Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Артериальная гипертония. Информированность, лечение, контроль. Укрепление здоровья и профилактика заболеваний 2001;4:3-7.

6. Леви Л., Андерсон А. Народонаселение, окружающая среда и качество жизни. М; Медицина; 1979.

7. Айвазян Т.А., Зайцев В.П. Исследование качества жизни больных гипертонической болезнью. Кардиология 1989;9:43-45.

8. Crooq S.H., Levine S., Testa M.A. et al. The effect of antihypertensive therapy on the quality of life. The New Engl J Med 1986; 314(26): 1657-1664.

9. Андреева Г.Ф., Горбунов В.М., Исайкина О.Ю., Лерман О.В., Воронина В.П. Сравнительная оценка воздействия малых доз эналаприла и телмисартана на качество жизни и гемодинамические показатели больных со стабильной артериальной гипертензией. Российский Кардиологический Журнал 2002;4:36-39.

10. Андреева Г.Ф., Марцевич С.Ю., Горбунов В.М. и др. Оценка действия комбинации бетагистина дигидрохлорида с антигипертензивными препаратами на качество жизни больных со стабильной артериальной гипертензией и головокружением. Кардиоваскулярная терапия и профилактика 2005; 3: 35-39.

11. Siegrist J., Junge A. Conceptual and methodological problems in research on the quality of life in clinical medicine. Soc. Sci. Med 1989; 29(3): 463-468.

12. Metelitsa V.I., Douda S.G., Ostrovskaya T.P. et al. Long – term monotherapy with antihy pertensives and quality of life in patients with mild to moderate arterial hypertension: a multictntre study J Drug Dev Clin Pract, 1996; 8(2): p. 61-76.

13. Zuther P., Witte K., Lemmer B. ABPM-FIT and CV-SORT: an easy-touse software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press Monit 1996;1:347-354.

14. Горбунов В.М., Оганов Р.Г., Деев А.Д. Сравнительная информативность различных способов анализа результатов суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии. Кардиоваскулярная терапия и профилактика 2003;1:17-25.

15. Parati G. Blood pressure reduction at night: sleep and beyond. J Hypertens; 2000: 1725-1729.

16. Mancia G., Omboni S., Ravogli A. et al. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Pressure 1995;4:148-156.

17. Андреева Г.Ф., Горбунов В.М., Айвазян Т.А. и др. Влияние темисартана на психологический статус и качество жизни больных со стабильной артериальной гипертензией. Экспериментальная и клиническая фармакология 2004; 67(6):36-40.

18. Crooq S.H., Levine S., Testa M.A. et al. The effect of antihypertensive therapy on the quality of life. The New Engl J Med 1986; 314(26): 1657-1664.

19. Pessano B., La Brocca A., Pozzallo G. et al. Antihypertensive efficacy end effects on quality of life of captopril in mild-to-moderate arterial hypertension. Minerva Med 1989;.80(6):.595 – 598.

20. Testa M.A., Anderson R.B., Nackley J.F. and Hollenberg N.R. Quality of life and antihypertensive therapy in man. New Engl J Med 1993; 328(13): 907-913.

21. Zubenko G.S., Nixon R.A. Mood elevating effect of captopril in depression patients. Am. J Psychiatry 1984; 141: 110-111.

22. Costall B., Kelly M.E., Naylor R.S. and Tomkins D.M. ACE inhibition and cognition. The international symposium on ACE inhibition. London 1989; Feb:14-17.

23. Baranowska D., Brazsko J.J. and Wisniewski K. Effect of angiotensin II and vasopression on acquisition and extinction of conditioned avoidance in rats. Psychopharmacology 1983;81:247-251.